WealthAI LimitedWealthAI Ltd.
UpgradeDownload on the App StoreLog inSign up free
Viewed today: —/2

Elite: read structure, select intervals, replay history

Explore linked evidence, interval analysis and replay in a complete case without signing in. Then try your own stock. Elite includes StockFlow from Plus and Radar research from Premium.

StockInvestingSI.com is a stock research and market information website: daily market briefings, company analysis, industry chains, and watchlist tools that help you follow stocks and understand market moves. Browse the homepage and selected research without signing in; create a free account to save your watchlist and keep up with the companies you follow. Operated by WealthAI Limited.

Research pages updated daily: S&P 500 and Nasdaq 100 stock analysis, industry supply-chain maps, and investment theme leaderboards, plus beginner guides. Start with a stock you follow: explore its analysis, understand its supply chain, and track related investment themes.

Today's close · Friday, October 30, 2026

Of 3779 stocks today, 8 are worth a closer look.

LLY: Doubler score 68 · Positive 3- and 6-month returns · Above the 200-day average · More estimate upgrades than downgrades. XOM: Doubler score 66 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades. REGN: Doubler score 66 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades.

StockFlow
LLY

Five technical factors give a separate short, medium and long-term leaning and probability.

LLYEli Lilly and Company+3.2%

Doubler score 68 · Positive 3- and 6-month returns · Above the 200-day average · More estimate upgrades than downgrades

10-30O 1428.83H 1449.68L 1408.36C 1417.54+3.19%MA20MA50
109611871279137114631234AE
  • A10-30 · LLY Maintained by Argus Research -- Pri…
  • E10-29 · Earnings
  • 107-30 · vs. S&P -6.2%
  • 210-14 · vs. S&P +4.7%
  • 310-29 · vs. S&P +7.0%
  • 410-30 · vs. S&P +5.0%
XOMExxon Mobil+2.2%
150160170180190

Doubler score 66 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades

REGNRegeneron Pharmaceuticals+13.3%
713771829886944

Doubler score 66 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades

GDYNGrid Dynamics+40.8%
7.28.810.412.013.6

Doubler score 78 · Positive 3- and 6-month returns · Above the 200-day average

CVXChevron+1.8%
184198211225239

Doubler score 66 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades

AZNAstraZeneca+7.0%
153162171180190

Doubler score 62 · Positive 3- and 6-month returns · Above the 200-day average

SPOTSpotify Technology+6.5%
465499533567600

Doubler score 62 · Positive 3- and 6-month returns · Above the 200-day average

CDNACareDx+22.2%
42.755.267.780.292.7

Doubler score 78 · Positive 3- and 6-month returns · Above the 200-day average · More estimate upgrades than downgrades